Using a field quantitative real-time PCR test to rapidly identify highly viremic Rift Valley fever cases

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1166-1171

  Njenga, M Kariuki ^a,f   Paweska, Janusz ^b   Wanjala, Rose ^a   Rao, Carol Y ^a   Weiner, Matthew ^c   Omballa, Victor ^a   Luman, Elizabeth T ^a   Mutonga, David ^d   Sharif, Shanaaz ^d   Panning, Marcus ^e   DroSten, Christian ^e   Feikin, Daniel R ^a   Breiman, Robert F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c US Naval Medical Research Unit No 3 Egypt   (Egypt)

^d MINISTRY OF HEALTH   (Kenya)

^e BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^f Centers for Disease Control and Prevention Kenya   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA;

ARTICLE; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER; HUMAN; KENYA; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER BUNYAVIRUS; RISK; VIREMIA; VIRUS DETECTION; EPIDEMIC; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MORTALITY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIROLOGY; VIRUS LOAD;

DISEASE OUTBREAKS; HUMANS; KENYA; MORTALITY; POLYMERASE CHAIN REACTION; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIREMIA;

EID: 65249106547     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01905-08     Document Type: Article

References (31)

1. Al-Afaleq, A. I., E. M. Abu Elzein, S. M. Mousa, and A. M. Abbas. 2003. A retrospective study of Rift Valley fever in Saudi Arabia. Rev. Sci. Tech. 22:867-871.
2. Al-Hazmi, M., E. A. Ayoola, M. Abdurahman, S. Banzal, J. Ashraf, A. El-Bushra, A. Hazmi, M. Abdullah, H. Abbo, A. Elamin, T. Al-Sammani, M. Gadour, C. Monon, M. Hamza, I. Rahim, M. Hafez, M. Jambavalikar, H. Arishi, and A. Aqeel. 2003. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans. Clin. Infect. Dis. 36:245-252.
3. Anyamba, A., K. J. Linthicum, and C. J. Tucker. 2001. Climate-disease connections: Rift Valley fever in Kenya. Cad. Saude Publica 17:133-140.
4. Bishop, D. H., C. H. Calisher, J. Casals, M. P. Chumakov, S. Y. Gaidamovich, C. Hannoun, D. K. Lvov, I. D. Marshall, N. Oker-Blom, R. F. Pettersson, J. S. Porterfield, P. K. Russell, R. E Shope, and E. G. Westaway. 1980. Bunyaviridae. Intervirology 14:125-143.
5. Centers for Disease Control and Prevention. 2007. Rift Valley fever outbreak-Kenya, November 2006-January 2007. MMWR Morb. Mortal. Wkly. Rep. 56:73-76.
6. Daubney, R., J. R. Hudson, and P. C. Granham. 1931. Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa. J. Pathol. Bacteriol. 34:545-579.
7. Drosten, C., S. Gottig, S. Schiling, M. Asper, M. Panning, H. Schmitz, and S. Gunther. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 40:2323-2330.
8. Duh, D., A. Sakida, M. Petrovec, S. Ahmeti, I. Dedushaj, M. Panning, C. Drosten, and T. Avsic-Zupanc. 2007. Viral load as predictor of CrimeanCongo hemorrhagic fever outcome. Emerg. Infect. Dis. 13:1769-1772.
9. El-Akkad, A. M. 1978. Rift Valley fever outbreak in Egypt, October-December 1977. J. Egypt. Public Health Assoc. 53:123-128.
10. Inuoye, R. T., L. A. Panther, C. M. Hay, and S. M. Hammer. 2002. Antiviral agents, p. 171-242. In D. D. Richman, R. J. Whitley, and F. G. Hayden (ed.), Clinical virology, 2nd ed. ASM Press, Washington, DC.
11. Gerdes, G. H. 2004. Rift Valley fever. Rev. Sci. Tech. 23:613-623.
12. Kärber, G. 1931. Beitrag zur kollectiven Behandlung pharmakologischer Reihensversuche. Arch. Exp. Pathol. Pharmacol. 162:480-483.
13. Ksiazek, T. G., P. E. Rollin, A. J. Williams, D. S. Bressler, M. L. Martin, R. Swanepoel, F. J. Burt, P. A. Leman, A. S. Khan, A. K. Rowe, R. Mukunu, A. Sanchez, and C. J. Peters. 1999. Clinical virology of Ebola hemorrhagic fever (EHF) : virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179:S177-S187.
14. Laughlin, L. W., J. M. Meegan, L. J. Strausbaugh, D. M. Morens, and R. H. Watten. 1979. Epidemic Rift Valley fever in Egypt: observations on the spectrum of human illness. Trans. R. Soc. Trop. Med. Hyg. 73:630-633.
15. Madani, T. A., Y. Y. Al-Mazrou, M. H. Al-Jeffri, A. A. Mishkhas, A. M. Al-Rabeah, A. M. Turkistani, M. O. Al-Sayed, A. A. Abodahish, A. S. Khan, T. G. Ksiazek, and O. Shobokshi. 2003. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. Clin. Infect. Dis. 37:1084-1092.
16. Meegan, J. M. 1981. Rift Valley fever in Egypt: an overview of epizootics in 1977 and 1978. Contrib. Epidemiol. Biostat. 3:100-113.
17. Meegan, J. M., and C. H. Bailey. 1988. Rift Valley fever, p. 51-76. In T. P. Monath (ed.), The arboviruses: epidemiology and ecology, vol. 4. CRC Press, Boca Raton, FL.
18. Nichol, S. T. 2001. Bunyavirus, p. 1603-1633. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
19. Paweska, J. T., F. J. Burt, and R. Swanepoel. 2005. Validation of IgGsandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. J. Virol. Methods 124:173-181.
20. Peters, C. J. 2000. California encephalitis, hantavirus pulmonary syndrome, and Bunyaviridae hemorrhagic fevers, p. 1849-1855. In G. I. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone, New York, NY.
21. Peters, C. J., J. A. Reynolds, T. W. Slone, D. E. Jones, and E. L. Stephen. 1986. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and macrophage activator. Antivir. Res. 6:285-297.
22. Saluzzo, J. F., J. P. Digoutte, C. Chartier, D. Martinez, and R. Bada. 1987. Focus of Rift Valley fever transmission in southern Mauritania. Lancet i:504.
23. Sanchez, A., A. S. Khan, S. R. Zaki, G. J. Nabel, T. G. Ksiazek, and C. J. Peters. 2001. Filoviridae: Marburg and Ebola viruses, p. 1279-1304. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
24. Sanchez, A., M. Lukwiya, D. Bausch, S. Mahanty, A. J. Sanchez, K. D. Wagoner, and P. E. Rollin. 2004. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J. Virol. 78:1037010377.
25. Sidwell, R. W., and D. F. Smeel. 2003. Viruses of the Bunyaand Togaviridae families: potential as bioterrorism agents and means of control. Antivir. Res. 57:101-111.
26. Srikiatkhachorn, A., C. Ajariyakhajorn, T. P. Endy, S. Kalayanarooj, D. H. Libraty, S. Green, F. A. Ennis, and A. L. Rothman. 2007. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J. Virol. 81:1592-1600.
27. Storch, G. A. 2001. Bunyaviruses, p. 493-531. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, PA.
28. Towner, J. S., P. E. Rollin, D. G. Bausch, A. Sanchez, S. M. Crary, M. Vincent, W. F. Lee, C. F. Spiropoulou, T. G. Ksiazek, M. Lukwiya, F. Kaducu, R. Downing, and S. T. Nichol. 2004. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J. Virol. 78:43304341.
29. Woods, C. W., A. M. Karpati, T. Grein, N. McCarthy, P. Gaturuku, E. Muchiri, L. Dunster, A. Henderson, A. S. Khan, R. Swanepoel, I. Bonmarin, L. Martin, P. Mann, B. L. Smoak, M. Ryan, T. G. Ksiazek, R. R. Arthur, A. Ndikuyeze, N. N. Agata, C. J. Peters, and World Health Organization Hemorrhagic Fever Task Force. 2002. An outbreak of Rift Valley fever in northeastern Kenya, 1997-98. Emerg. Infect. Dis. 8:138-144.
30. World Health Organization. 2007. Outbreak of Rift Valley fever in Kenya, Tanzania, and Somalia, December 2006-April 2007. Wkly. Epidemiol. Rec. 82:169-178.
31. Zeller, H. G., D. Fontenille, M. Traore-Lamizana, Y. Thiongane, and J. P. Digoutte. 1997. Enzootic activity of Rift Valley fever virus in Senegal. Am. J. Trop. Med. Hyg. 56:265-272.